SUCCESSFUL FERTILITY RESTORATION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

被引:15
|
作者
Gharwan, Helen [1 ]
Neary, Nicola M. [2 ]
Link, Mary [3 ]
Hsieh, Matthew M. [3 ]
Fitzhugh, Courtney D. [3 ]
Sherins, Richard J. [4 ]
Tisdale, John F. [3 ,4 ]
机构
[1] NCI, Med Oncol Branch, Bethesda, MD 20892 USA
[2] St George Hosp, Dept Endocrinol, London, England
[3] NHLBI, Mol & Clin Hematol Branch, Bethesda, MD 20892 USA
[4] Columbia Fertil Associates, Washington, DC USA
关键词
BONE-MARROW-TRANSPLANTATION; IRON OVERLOAD; DISEASE; HYPOGONADISM; PARAMETERS; HYDROXYUREA; RECIPIENTS; RADIATION; THERAPY;
D O I
10.4158/EP13474.CR
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Myeloablative conditioning regimens given prior to hematopoietic stem cell transplantation (HSCT) frequently cause permanent sterility in men. In patients with sickle cell disease (SCD) we use a nonmyeloablative regimen with sirolimus, alemtuzumab, and low-dose total-body irradiation (300 centigrays) with gonadal shielding preceding allogeneic HSCT. We report here the restoration of azoospermia in a patient with SCD after allogeneic HSCT. We discuss the impact of our patient's underlying chronic medical conditions and the therapies he had received (frequent blood transfusions, iron chelating drugs, ribavirin, hydroxyurea, opioids), as well as the impact of the nonmyeloablative conditioning regimen on male gonadal function, and we review the literature on this topic. Methods: We determined the patient's reproductive hormonal values and his semen parameters before, during, and after HSCT and infertility treatment. In addition, we routinely measured his serum laboratory parameters pertinent to SCD and infertility, such as iron and ferritin levels. A karyotype analysis was performed to assess the potential presence of Klinefelter syndrome. Finally, imaging studies of the patient's brain and testes were done to rule out further underlying pathology. Results: A 42-year-old man with SCD, transfusional iron overload, and hepatitis C underwent a nonmyeloablative allogeneic HSCT. One year later he desired to father a child but was found to be azoospermic in the context of hypogonadotropic hypogonadism. Restoration of fertility was attempted with human chorionic gonadotropin (2,000 IU) plus human menopausal gonadotropin (75 IU follicle-stimulating hormone) injected subcutaneously 3 times weekly. Within 6 months of treatment, the patient's serum calculated free testosterone value normalized, and his sperm count and sperm motility improved. After 10 months, he successfully initiated a pregnancy through intercourse. The pregnancy was uncomplicated, and a healthy daughter was delivered naturally at term. Conclusion: Despite exposure to several gonadotoxins, transfusional iron overload and nonmyeloablative conditioning with radiation causing severe testicular atrophy suggesting extensive damage to seminiferous tubules and possibly Leydig cells, gonadotropins were efficacious in restoring our patient's reproductive capability.
引用
收藏
页码:E157 / E161
页数:5
相关论文
共 50 条
  • [41] Cataract after allogeneic hematopoietic stem cell transplantation inchildhood
    Fahnehjelm, Kristina Tear
    Tornquist, Alba Lucia
    Olsson, Monica
    Backstrom, Ingrid
    Gronlund, Marita Andersson
    Winiarski, Jacek
    ACTA PAEDIATRICA, 2016, 105 (01) : 82 - 89
  • [42] Posaconazole concentrations after allogeneic hematopoietic stem cell transplantation
    Heinz, W. J.
    Einsele, H.
    Helle-Beyersdorf, A.
    Zirkel, J.
    Grau, A.
    Schirmer, D.
    Lenker, U.
    Klinker, H.
    TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (05) : 449 - 456
  • [43] Ocular Findings after Allogeneic Hematopoietic Stem Cell Transplantation
    Tabbara, Khalid F.
    Al-Ghamdi, Ahmad
    Al-Mohareb, Fahad
    Ayas, Mouhab
    Chaudhri, Naeem
    Al-Sharif, Fahad
    Al-Zahrani, Hazzaa
    Mohammed, Said Y.
    Nassar, Amr
    Aljurf, Mahmoud
    OPHTHALMOLOGY, 2009, 116 (09) : 1624 - 1629
  • [44] Epileptic Seizures After Allogeneic Hematopoietic Stem Cell Transplantation
    Wang, Zhuo
    Zhao, Munan
    Gao, Sujun
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [45] Visceral leishmaniasis after allogeneic hematopoietic stem cell transplantation
    H J Agteresch
    M B van 't Veer
    J J Cornelissen
    J F Sluiters
    Bone Marrow Transplantation, 2007, 40 : 391 - 393
  • [46] Allogeneic hematopoietic stem cell transplantation
    Faul, C.
    ONKOLOGIE, 2012, 35 : 112 - 112
  • [47] Allogeneic hematopoietic stem cell transplantation
    Kai, S
    Hara, T
    THERAPEUTIC APHERESIS AND DIALYSIS, 2003, 7 (03) : 285 - 291
  • [48] Adoptive immunotherapy ± Ruxolitinib and second allogeneic hematopoietic stem cell transplantation in patients with relapsed Myelofibrosis after allogeneic hematopoietic stem cell transplantation
    Bogdanov, R.
    Ditschkowski, M.
    Steckel, N. -K.
    Klisanin, V.
    Kordelas, L.
    Trenschel, R.
    Beelen, D. W.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 60 - 61
  • [49] Successful treatment of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation with bortezomib
    Cao, Ling
    Koh, Liang Piu
    Linn, Yeh Ching
    LEUKEMIA & LYMPHOMA, 2018, 59 (10) : 2500 - 2502
  • [50] Successful allogeneic hematopoietic stem cell transplantation (HSCT) for Shwachman–Diamond syndrome
    J Fleitz
    S Rumelhart
    F Goldman
    D Ambruso
    RJ Sokol
    D Pacini
    R Quinones
    M Holida
    N Lee
    R Tannous
    R Giller
    Bone Marrow Transplantation, 2002, 29 : 75 - 79